TDDA are proud to announce the soon to be released updated TDDA branded oral fluid and urine screening devices that includes the option of 2 extra drug types “Tramadol & Fentanyl”. The development of these new screening devices is part of TDDA’s ongoing commitment...
Content by TDDA
Opinion Piece: Time to Reevaluate the Medicinal Cannabis Framework
By Glenn Dobson, CEO of The Drug Detection Agency (TDDA) The rapid expansion of the medicinal cannabis market in Australia and New Zealand raises significant concerns about workplace safety and public health. As someone deeply committed to maintaining drug-free and...
Opinion: Leadership Must Prioritise Managing Workplace Safety Risks
By Glenn Dobson, CEO of The Drug Detection Agency The recent media reports relating to the New Zealand court ruling following the tragic death of a worker at the Port of Auckland have underscored the critical role of leadership in workplace health and safety...
TDDA sponsor the Australian HR Institute (AHRI) in Hobart, Tasmania
Last week, TDDA proudly served as one of the seven sponsors at the Australian HR Institute (AHRI) state conference, held at the Crowne Plaza in Hobart, Tasmania. TDDA’s Rhonda Oliver and Clint Dale represented the company, engaging with 130 HR delegates. The event...
‘Living document’: Employers urged to keep drug-testing policies updated amid shifting trends
In this insightful article, Glenn Dobson discusses the critical need for employers to regularly update their drug and alcohol policies to ensure compliance with shifting legal frameworks and emerging workplace trends. With rising concerns around THC use and opioid...
TDDA Launches Imperans Report, a New Quarterly Workplace Drug Use Snapshot
Imperans Report to Provide Businesses with Actionable Health and Safety Information AUCKLAND, New Zealand, 04 November 2024 – The Drug Detection Agency (TDDA), New Zealand’s largest workplace drug testing provider, has launched the Imperans Report, its new quarterly...
AUSTRLALIA & NEW ZEALAND’S MEDICINAL CANNABIS MARKET – LEGITIMATE MEDICINE OR LEGALISATION UNDER ANOTHER NAME?
October 2024 As the CEO of TDDA, it is critical to highlight the increasing safety risks surrounding the shift from CBD-dominant medicinal cannabis products to high-THC products in New Zealand and Australia. Originally, medicinal cannabis was intended to offer...
TDDA Hosts Expert Workshops on “Workplace Drug Testing… A Glimpse into the Future”
The Drug Detection Agency (TDDA) is currently hosting a series of expert workshops across New Zealand and Australia, providing a valuable look into the future of workplace drug testing. These interactive events are taking place in key locations, including Auckland,...
Drug Testing Politicians: A Call for Accountability in All Workplaces – October 2024
Recent revelations of corruption at Moonee Valley Council have uncovered serious allegations of drug-related misconduct. An IBAC report found that a former mayor accepted drugs such as cocaine and Xanax in exchange for expediting property developments and bypassing...
TDDA – Victoria Parliament Inquiry into Workplace Drug Testing – October 2024
Introduction: Workplace safety is paramount for every industry, and drug testing is a vital component of maintaining a safe and productive environment. At The Drug Detection Agency (TDDA), we believe that workplace drug testing not only enhances safety but also...